PS.

THH - Supply of Patient-Specific Cytotoxic and Advjuvant Products

The Hillingdon Hospitals NHS Foundation TrustcontractFind a Tender ↗Ref ocds-h6vhtk-05e0ecProcurement Act 2023SME suitableVCSE suitablepending

Estimated value

—

Awarded value

£9.3m

Awarded 27 May 2026

Suppliers

1

Lots

1

1 awarded

Published

10 Jun 2026

Description

Provision of Patient specific Cytotoxic and Adjuvant products as and when required.

Scope

Reference
C392954
Commercial tool
Standalone contract
Contract dates
03 Feb 2026 to 02 Feb 2029
Possible extension to 02 Feb 2031

Option to extend by 24 months based on trust requirements

CPV classifications
33000000
Particular suitability
Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
CommercialCommercialcost30.00%
technicalTechnicalquality60.00%
Social Value EnvelopeSocial Valuequality10.00%

Participation

Conditions suppliers must meet to bid.

Included within ITT packs

Submission & procedure

Procedure
Open procedure

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£9.3m

Award date

27 May 2026

Contract start

30 Jun 2026

Contract end

30 Jun 2029

Awarded to
BA
Baxter
CH 00461365